In July 2026, the Novo Nordisk Foundation announced nine research grants worth up to €10 million each. Seven of them went to principal investigators based outside Denmark — Vienna, Helsinki, Rotterdam, Szeged, Birmingham, Stockholm, Geneva. It was the first year the programme allowed non-Danish researchers to lead, and roughly 78% of the money promptly left the country.
If Danish research foundations have never appeared in your funding portfolio, that is the number worth sitting with. Not because Denmark is a charming special case, but because the densest private research-funding system on earth quietly changed its eligibility rules and most of Europe did not notice.
The scale outside Denmark nobody quite believes
Danish foundations distributed DKK 26.1 billion — roughly €3.5 billion — to public-benefit purposes in 2023. That is 0.9% of Danish GDP, from a country of 5.9 million people.
The comparison that makes it land: this is a similar order of magnitude to Denmark's entire annual defence budget, redirected into research, culture, health and social work by private boards.
The Novo Nordisk Foundation alone paid out DKK 10.1 billion (€1.35 billion) across roughly 1,800 projects in 2024 — the first time any Danish foundation crossed that line in a single year. For scale, that single foundation's annual disbursement is comfortably larger than the entire annual budget of many national research councils.
What this produces is unusual, and it is the thing worth understanding before you look at any individual call. In most European systems, private foundations top up a state apparatus. In several Danish domains — basic life science, cultural heritage, built environment — it runs the other way. The foundations are the primary funder and the state plays a supporting role.
That inversion has a practical consequence. Foundation money behaves differently from council money, and the instincts you have built applying to national agencies will partly mislead you. If you have not worked with private funders before, the differences in how foundations evaluate proposals matter more than the differences in application form.
Three boardrooms decide nearly half the money
The 100 most-distributing Danish foundations gave DKK 23.7 billion in 2023. Three of them accounted for DKK 10.8 billion of it — about 46%.
| Foundation | 2023 distribution (DKK) | Primary focus |
|---|---|---|
| Novo Nordisk Fonden | 7,691m | Life science, biotech, health, planetary health |
| A.P. Møller og Hustru Chastine McKinney Møllers Fond | 1,773m | Broad public benefit, heritage, medical research |
| LEGO Foundation | 1,345m | Learning through play, education |
| Den A.P. Møllerske Støttefond | 1,153m | Social, cultural, educational |
| Villum Fonden | 1,149m | Technical and natural sciences, environment |
| Realdania | 756m | Built environment, quality of life |
| Carlsbergfondet | 706m | Basic research across natural sciences, humanities, social sciences |
| Lundbeckfonden | 592m | Neuroscience (see below — 2024 was very different) |
Source: Fondenes Videnscenter, top 100 Danish foundations, 2023.
Two things follow from that concentration, and the second one is the useful one.
The obvious point is that Danish funding is not a long-tail exercise. The bottom seventy of the top hundred, combined, distribute less than the top three alone.
The less obvious point is about where you spend your preparation time. Researchers approaching an unfamiliar national system tend to build a spreadsheet of forty plausible funders and allocate attention evenly across it. In Denmark that is close to the worst possible allocation. Four or five foundations are worth genuinely understanding — their portfolios, their programme officers, their recently funded projects. The remaining ninety-five are worth a keyword search and nothing more.
What "open to non-Danish applicants" actually means
Here is where enthusiasm needs a hard edge, because the headline is more open than the fine print.
The Novo Nordisk Foundation's Challenge Programme awarded up to DKK 600 million (€80 million) in 2026, with each of nine consortia receiving up to DKK 75 million (€10 million) over six years. Applications were invited, for the first time, from researchers based in the European Schengen area, Ireland and the UK.
But the requirement that matters is this: each consortium must include two to four research groups, and at least one applicant must be based at a Danish university, hospital or non-profit research organisation. All nine funded projects included Danish partners.
So this is not an open international call. It is a collaboration instrument with a Danish anchor requirement, and the distinction changes your entire approach. Your route in is not a better proposal. It is a Danish co-applicant whose work genuinely complements yours — which is a relationship you build over months, not something you assemble three weeks before a deadline.
The 2026 cycle also shows how the calendar works. Expressions of interest were due in October 2025; awards were announced in July 2026. That is a nine-month evaluation arc, which means the preparation is front-loaded and the cash is distant. Anyone modelling this as runway needs to count from the announcement, not the submission.
Eligibility varies sharply by instrument, and this is the table I wish someone had handed me:
| Instrument | Who can apply | Notes |
|---|---|---|
| NNF Challenge Programme | PI in Schengen area, Ireland or UK | Requires ≥1 Danish-based applicant; consortium of 2–4 groups |
| NNF Emerging Investigator | Researchers at institutions in Denmark, Finland, Iceland, Norway or Sweden | Genuinely Nordic-wide, no Danish anchor needed |
| NNF Start Package / RECRUIT | Any nationality, but must be recruited to a Danish institution | Nomination by a Danish university required for RECRUIT |
| Lundbeckfonden (most instruments) | Predominantly Danish-hosted research | Check each call; neuroscience only in practice |
| Carlsbergfondet | Largely Danish-affiliated researchers | Open competition, basic research |
Do not read "Denmark funds international research" as "Denmark funds you where you are." Several of these instruments are recruitment tools — designed to make Danish institutions more competitive when hiring, not to export Danish money. Being precise about which category a call falls into saves a great deal of wasted effort.
Why Danish research foundations select on mandate, not polish
The single most useful thing to understand about Danish research foundations is that they select on mandate fit far more than on proposal craft.
The Lundbeck Foundation crossed DKK 1 billion in philanthropic grants for the first time in its 70-year history in 2024 — DKK 1,074 million, of which DKK 947 million, or 88%, went to neuroscience. One line of an annual report tells you everything about your odds. If your project is not neuroscience, no amount of framing will fix the fit, and skilled framing will actively hurt you because evaluators recognise a stretch.
That pattern repeats across the system. Industriens Fond narrowed to four themes and stopped pretending otherwise. Augustinus Fonden puts more than 80% of its grants into Danish cultural life. Villum Fonden lives in technical and natural sciences. Realdania funds the built environment and essentially nothing else.
The discipline this should produce is uncomfortable but simple: map your project against three to five candidate mandates before any writing happens, and refuse to apply anywhere the fit needs more than a paragraph of justification.
There is a genuine upside to this rigidity, and it is easy to miss. Foundation mandates do not reset every two years the way framework-programme calls do. A neuroscientist can build a decade-long relationship with Lundbeckfonden knowing the thematic ground will not shift underneath them. That stability is rare, and it rewards patience in a way that competitive call cycles never do. It also means the unwritten cultural rules of a national funding system are worth learning once, because they keep paying out.
The grant that deliberately ignores your CV
Buried inside the same foundation that concentrates 88% of its money in neuroscience is one of the most unusual instruments in European research funding, and it deserves attention out of proportion to its size.
The LF Experiment grant funds deliberately risky neuroscience — projects where the hypothesis may well not survive the lab. In 2024 it received around 250 applications and funded 30 of them with DKK 60 million over two years, up to roughly DKK 2.3 million each. A 12% hit rate is unremarkable on its own.
What makes it remarkable is the evaluation rule: assessment is based on the idea itself, not on previous scientific merits. Not weighted toward the idea. Based on it.
For anyone who has watched a good proposal lose to a thinner one attached to a longer publication list, that sentence is worth reading twice. Most funders claim to reward novelty and then quietly reward track record, which is the mechanism behind the track-record paradox that traps early-career applicants. An instrument that formally removes prior output from the assessment is a structurally different game, and it is hospitable to precisely the work that struggles elsewhere: the half-formed idea with no preliminary data behind it yet.
The application is short, and the effort-to-odds ratio is consequently among the best available anywhere in Europe. One caveat worth budgeting for: indirect costs are capped at around 10%, which is typical of private foundations and a long way from a negotiated university overhead rate. Your finance office will notice.
If your work is closer to a company than a paper
Denmark also has a route that does not involve a grant application at all, and it is easy to miss because it does not look like funding.
The BioInnovation Institute, established by the Novo Nordisk Foundation, has supported 142 startups to date, which have gone on to attract around €1.1 billion in external funding against roughly €145 million deployed by BII itself. Its Venture Lab programme offers up to DKK 4 million, and Bio Studio up to DKK 5.35 million per year, alongside lab infrastructure and investor access that a spinout cannot easily buy.
Twenty-one products from its portfolio are on the market. For pre-seed life science and deeptech, that combination — capital, wet-lab space, and a warm investor network in one place — is genuinely hard to replicate elsewhere in Europe.
The reason to mention it in a piece about foundations is structural. If your research has a translational path, the Danish system offers something most national systems do not: a continuous chain from basic-research grant to incubator to follow-on capital, funded largely by the same handful of foundations. You can move along that chain without leaving the ecosystem, which is a meaningfully different proposition from winning a grant and then starting a fundraise from zero.
The intelligence tool almost nobody uses
Since 2024, Denmark has published something most countries do not: a searchable database of who actually got funded.
Research Portal Denmark, built by NORA with Fondenes Videnscenter and Statistics Denmark, holds just over 8,300 grants from 2016 onward, searchable project by project at grants.forskningsportal.dk. Independent Research Fund Denmark, the Novo Nordisk Foundation and the Carlsberg Foundation are live; Lundbeckfonden, Innovation Fund Denmark, VELUX FONDEN and Villum Fonden joined in 2025. It covers both Danish and foreign grant recipients.
Most applicants write proposals against their guess about what a funder wants. Here you can simply look. Before drafting, you can see what that foundation funded in your area for the past nine years, at what amounts, to whom, and how your idea sits against the existing portfolio — including whether the thing you think is novel was funded in 2019.
That is the highest-return hour available anywhere in this process, and it is free.
Where Danish research foundations belong in your portfolio
None of this is an argument for applying to Danish foundations instead of the European schemes you already know. The ERC is not replaceable, and Horizon Europe's collaborative instruments do things no private foundation does.
It is an argument about contested space. Every European researcher in your field is optimising for the same ERC and Horizon deadlines, which is precisely why the less-crowded instruments inside Horizon Europe tend to have better odds than the flagship calls. Danish foundation money sits further along that same logic: large, stable, mandate-driven, and — for a while yet — under-applied by people outside Denmark. The same reasoning applies to cross-border fellowship routes that most candidates never check.
The honest summary is this. Danish research foundations will not take your project because it is excellent. They will take it because it is excellent and it sits squarely inside a mandate that has not changed in twenty years and you found the right Danish collaborator. Two out of three is a rejection.
But seven of nine grants in the first open round of an €80 million programme went to PIs outside Denmark. The door is not theoretically open. It has already been walked through, by people who read an eligibility change that everyone else scrolled past.